Compounds > pyridoxal phosphate

pyridoxal phosphate and inositol 1,4,5-trisphosphate

pyridoxal phosphate has been researched along with inositol 1,4,5-trisphosphate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breittmayer, JP; Feolde, E; Frelin, C; Pacaud, P; Urbach, V; Vigne, P1
Boeynaems, JM; Communi, D; Robaye, B1
Boarder, MR; Kumari, R; London, NJ; Ng, LL; Porter, KE; White, PJ1
Boeynaems, J; Pouillon, V; Robaye, B; Suarez-Huerta, N1
Braet, K; Evans, WH; Leybaert, L; Martin, PE; Vandamme, W1

Other Studies

5 other study(ies) available for pyridoxal phosphate and inositol 1,4,5-trisphosphate

ArticleYear
The effect of PPADS as an antagonist of inositol (1,4,5)trisphosphate induced intracellular calcium mobilization.
    British journal of pharmacology, 1996, Volume: 119, Issue:2

    Topics: Adenosine Triphosphate; Animals; Brain; Calcium; Calcium Channels; Cytosol; Drug Interactions; Endothelium, Vascular; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Inositol Phosphates; Intracellular Fluid; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2; Uridine Triphosphate

1996
Slow desensitization of the human P2Y6 receptor.
    European journal of pharmacology, 1997, Jun-25, Volume: 329, Issue:2-3

    Topics: Adenosine Diphosphate; GTP-Binding Proteins; Humans; Inositol 1,4,5-Trisphosphate; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Suramin; Triazines; Tumor Cells, Cultured; Uridine Diphosphate

1997
Antiproliferative effect of UTP on human arterial and venous smooth muscle cells.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Calcium; Cell Division; Cells, Cultured; Humans; Inositol 1,4,5-Trisphosphate; Mammary Arteries; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Saphenous Vein; Suramin; Thymidine; Tritium; Type C Phospholipases; Uridine Triphosphate

2000
Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.
    European journal of pharmacology, 2001, Mar-30, Volume: 416, Issue:3

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Antineoplastic Agents; Cloning, Molecular; Dose-Response Relationship, Drug; Humans; Inositol 1,4,5-Trisphosphate; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Rats; Receptors, Purinergic P2; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Suramin; Transfection; Triazines; Tumor Cells, Cultured; Uridine Triphosphate

2001
Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26.
    Cell calcium, 2003, Volume: 33, Issue:1

    Topics: Adenosine Triphosphate; Animals; Apyrase; Calcium; Calcium Signaling; Cell Communication; Cells, Cultured; Chelating Agents; Connexins; Endothelium; Fluorescence Recovery After Photobleaching; Gap Junctions; Glycyrrhetinic Acid; Inositol 1,4,5-Trisphosphate; Peptides; Photolysis; Pyridoxal Phosphate; Rats; Second Messenger Systems; Signal Transduction

2003